Katharina Grif

Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome

Dorothea Orth‐Höller, Abdul Basit Khan, Asma Naim et al. · The Journal of Immunology · 2009 · 209 citations · Full text

Life Sciences, Infectious Diseases, Pathobiology +17

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome

Dorothea Orth‐Höller, Katharina Grif, Abdul Basit Khan et al. · Diagnostic Microbiology and Infectious Disease · 2007 · 173 citations

Medicine, Nephrology, Pathobiology +11

Strain-Specific Differences in the Amount of Shiga Toxin Released from Enterohemorrhagic Escherichia coli O157 following Exposure to Subinhibitory Concentrations of Antimicrobial Agents

Katharina Grif, M P Dierich, Helge Karch et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1998 · 153 citations

Life Sciences, Infectious Diseases, Microbiology +16

Incidence of Fecal Carriage of Listeria monocytogenes in Three Healthy Volunteers: A One-Year Prospective Stool Survey

Katharina Grif, G. Patscheider, M. P. Dierich et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2003 · 131 citations

Agriculture, Food Science, Microbiology +9

In vitro activity of fosfomycin in combination with various antistaphylococcal substances

Katharina Grif · Journal of Antimicrobial Chemotherapy · 2001 · 122 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +15